33.12
price up icon13.23%   3.87
after-market Dopo l'orario di chiusura: 33.40 0.28 +0.85%
loading

Mineralys Therapeutics Inc Azioni (MLYS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.17%
46.75
44.45 60.11 45.17 35.36
Operating Income/Loss
5.17%
-46.75
-44.45 -60.11 -45.17 -35.36
Nonoperating Income/Loss
55.28%
3.472
2.236 3.764 4.154 3.854
Income/Loss From Continuing Operations Before Tax
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Income/Loss From Continuing Operations After Tax
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Net Income/Loss
2.52%
-43.27
-42.21 -56.34 -41.01 -31.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23.11%
65.45
53.16 49.82 49.36 44.90
Diluted Average Shares
23.11%
65.45
53.16 49.82 49.36 44.90
Basic Earnings Per Share
16.46%
-0.66
-0.79 -1.13 -0.83 -0.70
Diluted Earnings Per Share
16.46%
-0.66
-0.79 -1.13 -0.83 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):